Skip to content
  • Sunday, 16 August 2026
  • 3:27 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Breakthrough in IVF Technology Uses Oviduct Glycans to Extend Sperm Viability and Improve Fertilization Rates
Stem Cell & Regenerative Medicine

Breakthrough in IVF Technology Uses Oviduct Glycans to Extend Sperm Viability and Improve Fertilization Rates

Dwi Wanna May 13, 2026 0

In a significant advancement for reproductive medicine and agricultural science, researchers at the University of Illinois Urbana-Champaign have developed a…

Read More
Stem Cell & Regenerative Medicine

Breakthrough in IVF Research Uses Oviduct Glycans to Extend Sperm Viability and Improve Embryo Success Rates

Dwi Wanna Mar 20, 2026 0

In vitro fertilization (IVF) has long been a cornerstone of both human reproductive medicine and global agricultural productivity. However, despite…

Read More
Japanese Researchers Identify Key Protein Interaction Regulating Sperm Development and Male FertilityHarnessing Site Performance for Superior Cardiometabolic Clinical Trial OutcomesADA Conference Highlights: GLP-1 Innovations Reshape Metabolic Treatment Landscape Amidst Unprecedented Scientific Advocacy ProtestThe biotech bi-weekly: partnerships facilitating antibody discovery and AI drug development
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ